Advaxis, Inc. Science & Operations Officer Moderates Live Vaccine Panel at Cancer Drug Research Conference

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Dr. John Rothman, EVP of Science & Operations of Advaxis, Inc., (OTCBB: ADXS) the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, moderated a panel discussion titled, “Live Cancer Vaccines.”